Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CRBG
CRBG logo

CRBG Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Corebridge Financial Inc (CRBG) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
26.280
1 Day change
-2.16%
52 Week Range
36.570
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Corebridge Financial Inc (CRBG) does not present a compelling buy opportunity for a beginner, long-term investor at this time. Despite some positive technical indicators, the lack of strong growth in financials, declining analyst price targets, and hedge fund selling trends suggest caution. The investor's funds would be better allocated elsewhere for now.

Technical Analysis

The MACD is positive and expanding (0.491), indicating bullish momentum. RSI is at 79.938, which is in the neutral zone but nearing overbought territory. Moving averages are converging, showing no clear trend. The stock is trading near its resistance level (R1: 26.959), suggesting limited upside potential in the short term.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
5

Positive Catalysts

  • The MACD indicates bullish momentum. Appointment of a new interim CFO and merger with Equitable Holdings could provide long-term strategic benefits.

Neutral/Negative Catalysts

  • Hedge funds are aggressively selling (2778.97% increase in selling). Analyst price targets have been consistently lowered, reflecting concerns about the life insurance sector. Financial performance in Q4 2025 showed a significant decline in net income (-62.51% YoY) and EPS (-57.89% YoY).

Financial Performance

In Q4 2025, revenue increased modestly by 2.53% YoY to $6.77 billion. However, net income dropped significantly by 62.51% YoY to $814 million, and EPS fell by 57.89% YoY to 1.6. Gross margin remained flat at 0%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts maintain generally positive ratings (Buy/Outperform), but price targets have been consistently reduced, with the latest targets ranging from $30 to $40, down from prior higher levels. Analysts cite challenges in the life insurance sector, including competition and valuation pressures.

Wall Street analysts forecast CRBG stock price to rise
10 Analyst Rating
Wall Street analysts forecast CRBG stock price to rise
7 Buy
3 Hold
0 Sell
Moderate Buy
Current: 26.860
sliders
Low
33
Averages
37.3
High
40
Current: 26.860
sliders
Low
33
Averages
37.3
High
40
BofA
Buy
maintain
$42 -> $40
AI Analysis
2026-04-14
Reason
BofA
Price Target
$42 -> $40
AI Analysis
2026-04-14
maintain
Buy
Reason
BofA lowered the firm's price target on Corebridge to $40 from $42 and keeps a Buy rating on the shares. The firm adjusted price target among its U.S. insurance coverage to reflect Q4 events and changes to peer multiples.
Mizuho
Yaron Kinar
Outperform
to
Outperform
downgrade
$39 -> $31
2026-04-13
Reason
Mizuho
Yaron Kinar
Price Target
$39 -> $31
2026-04-13
downgrade
Outperform
to
Outperform
Reason
Mizuho analyst Yaron Kinar lowered the firm's price target on Corebridge to $31 from $39 and keeps an Outperform rating on the shares. The firm adjusted estimates and targets among its North America insurance coverage, stating that it is most constructive on brokers, expects commercial pricing pressure moderation among property and casualty insurers and believes the setup for life insurers is "the most challenging."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CRBG
Unlock Now

People Also Watch